Alnylam Pharmaceuticals: BMO cuts target price to $290 from $318
ALNY•BMO cut its target price for Alnylam Pharmaceuticals to $290 from $318.
Related News
Jefferies raises Exelixis target price to $76 from $70
EXEL•
Asian spot LNG prices rise to new multi-year high on Mideast tensions and buying interest
UNG•
Gates Industrial Q3 adjusted EPS $0.47 vs. estimate of $0.44
GTES•
Mondelez: Stifel raises target price to $74 from $68
MDLZ•
Xcel Energy: Mizuho cuts target price to $86 from $92
XEL•